UAE Sees Rise in Atrial Fibrillation Cases, Pioneering New Treatment Options

The United Arab Emirates is witnessing an increase in atrial fibrillation (AFib) cases, driven by factors such as rising life expectancy and a growing prevalence of chronic diseases. Early diagnosis and treatment are crucial to preventing serious complications like stroke and heart failure, according to leading cardiologists in the region.

Understanding Atrial Fibrillation

Atrial fibrillation is the most common type of heart rhythm disorder, characterized by a rapid and irregular heartbeat. It often develops silently in its early stages, making early detection particularly important. Risk factors include high blood pressure, diabetes, and obesity, all of which place continuous stress on the heart and can alter the heart muscle structure and electrical signaling mechanisms.

The Importance of Prevention and Lifestyle

Controlling risk factors through a healthy lifestyle – including a balanced diet, regular exercise, and maintaining a healthy weight – and consistent medical check-ups are essential for preventing AFib. Addressing underlying conditions like hypertension and diabetes is also critical for protecting heart health and improving quality of life.

Advancements in AFib Treatment: The “Volt PFA” Technology

Traditional cardiac cauterization techniques have proven effective in treating AFib, but can sometimes affect surrounding heart tissue. To address this, innovative technologies are emerging. Dr. Mohamed Magdy, Head of the Cardiac Electrophysiology Department at Al Qassimi Hospital in Sharjah, highlights the “Volt PFA” technology developed by Abbott as a significant advancement.

Volt PFA utilizes precisely directed electrical energy to target the cells causing the arrhythmia, preserving healthy tissue. This enhances the accuracy of the procedure and improves treatment outcomes. Benefits for patients include increased safety, shorter procedure times, faster recovery, and a reduced risk of complications.

UAE’s Role in Cardiac Innovation

The adoption of modern technologies like Volt PFA is streamlining medical procedures and enabling more patients to receive timely care. Dr. Magdy also led Europe’s first implantation of a single-chamber, wireless cardiac pacemaker “Aveir VR” at Bern University Hospital in Switzerland, demonstrating the UAE’s growing prominence in global healthcare [EHS].

The Volt PFA technique is suitable for patients with both early and persistent stages of atrial fibrillation, though treatment selection is based on individual medical evaluation.

Recognizing the Symptoms and Seeking Early Examination

Dr. Magdy emphasizes the importance of not ignoring symptoms such as irregular heartbeat, unexplained fatigue, or shortness of breath. Early examination can significantly improve therapeutic results and maintain heart health.

Expert Profile: Dr. Mohamed Magdy

Dr. Mohamed Magdy Mohamed Abbas is the Head of the Cardiac Electrophysiology Department at Al Qassimi Hospital, Sharjah, since 2013. He is also a Professor of Critical Care Cardiology and Electrophysiology at Cairo University and a Professor of Cardiology at the University of Sharjah [Medcare]. He is also the Clinical Director for heart block management JCI program and Chairman and Director of the GULF EP LIVE meeting [ESC 365].